ADIPOQ and obesity disorder: Summing up, the conducted studies have indicated the participation of adipocytokines—the biologically-active mediators of the systemic metabolism—such as leptin and adiponectin, in the pathomechanisms of disorders underlying obesity which, in turn, leads to the development of insulin resistance and consequently contributes to the occurrence of type 2 diabetes.